Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Dauntless who wrote (3836)	5/3/1998 2:27:00 PM
From: Hank	Read Replies (1) \| Respond to of 7041

I think the new comer can accurately assume that I am on the short side of this debate from what I posted. It seems too obvious to have to be said. Even if I wasn't on the short side of this stock, I would advise anybody from investing in ZONA. At the current prices it is extremely over valued and is about as high risk an investment as you can find. There are better ways to make money on the long side with far better companies. As for the milestone payments, I was under the impression that the next payment will be made IF Vasomax gets approval, not just filed. I have never seen it stated any differently anywhere else. Furthermore, it makes no sense to give ZONA money if the NDA gets filed since SGP is the one doing the filing. If you can me point towards a reputable source of information that proves otherwise, I will believe you. However, I believe ZONA's last quarterly statement viewable at the SEC web site lays out the milestone payments just as I've stated. As for the law suits, it like they always say, it ain't over till the fat lady sings. Now the only question is, what will we do with David and Linda?